DR . NARENDRAN'S SITUATION

Submitted in partial fulfilment of the requirements of the course WRITTEN RESEARCH AND CONVERSATION – We

To

Dr . Narendran

Director

American indian Medicine (Siddha) College

Chennai.

Subject: Examine of effects of commercialization of Doctor Ramkumar's ingredients Respected Sir,

As instructed by the director of WIMWI, I have comprehensively examined the background of IMC, its objectives, the scope of Dr . Ramkumar's formula and analysed the impact of its commercialization on IMC as well as the Siddha system of medicine. Based on this kind of study, I use worked out a strategy which would be in the needs of all parties concerned. Please find the report surrounded.

Yours seriously,

Student, WIMWI

Ahmedabad.

EXECUTIVE SUMMARY:

IMC promotes education, medical care and development of the Siddha medical system. Dr . Ramkumar offers invented a formulation that reduces usage of commercial stents in angioplasty, which he wants to acquire patented through IMC. This kind of invention supplies IMC using a unique opportunity of increasing presence of the Siddha medical system vis-à-vis other parallel devices of medicine. Additionally, it gives IMC the chance to create revenue by itself which can be channelled into infrastructural development of IMC's hospital. Offloading the patent for a one time license charge is recommended since IMC is without prior knowledge in the commercialisation of the research. [Word Depend = 75 ]

TABLE OF CONTENTS

Executive Summary…………………………………………………………………………3 Situational Analysis…………………………………………………………………………. five The Problem……………………………………………………………………. ……………5 The Options………………………………………………………………………………….. a few Criteria intended for Evaluation………………………………………………………………………. 6 Evaluation of Options………………………………………………………………………. 6 The Recommendation………………………………………………………….. …………10 Actions Plan…………………………………………………………………. ………………10 References…………………………………………………………………………………. 10

SITUATIONAL ANALYSIS:

Dr . Ramkumar, Associate Mentor and Brain of the Pharmacology Department of IMC, has come up with a formulation that reduces the need for stents during angioplasty. This individual wishes to get his formulation branded through IMC and commercialise it since he is convinced that this will assist IMC academically and economically. Dr . Narendran, director of IMC, can be apprehensive of taking this step, since the domain name of patents and commercialization is completely new -- not only to IMC, although also to the Siddha approach to medicine. Yet , he likewise recognises that IMC needs funds to grow further more and that actions need to be taken to make the Siddha acceptable between other seite an seite systems of drugs. The patent can help the Siddha program gain identification and enable IMC to reap monetary rewards. THE PROBLEM:

A conclusion needs to be considered regarding Dr . Ramkumar's ask for. If IMC gets the obvious, then the course of action needs to be cautiously worked upon, since IMC has no preceding experience from this field. THE ALTERNATIVES:

The options accessible to Dr . Narendran are:

* To never apply for a obvious for Doctor Ramkumar's formula. * To apply for a patent for Dr . Ramkumar's ingredients. In case the patent is definitely granted, IMC has three or more options: 5. Sell the patent for the one-time permit fee to a third-party. 5. Employ a pharmaceutic unit to manufacture the formulation, while IMC requires responsibility for its marketing and operations. * To rope within an entrepreneur who will pay IMC annual royalties at 6% of the revenues every year until the obvious is valid. CRITERIA PERTAINING TO EVALUATION:

* Your decision taken needs to be guided by mandate of IMC. Providing Siddha education, Siddha medical care and marketing the science of Siddha will be the key targets of IMC. * The decision will have a direct impact on the other teachers members as well. While on a singke hand, Dr . Ramkumar's colleagues think that he is deceptive and does not discuss his expertise with others, but on the other hand, you will find two additional faculty associates who are working on formulations as significant...

References: 0. 3 | Rs. 75000

Exhibit 1: Probability distribution of expected permit fee

From Exhibit you,

Expected benefit of the permit fee will probably be: 0. 7(50000) + zero. 3(75000) sama dengan Rs

Coming from Exhibit 3, the total vips accumulated in 5 years from sale for product inside India can be estimated for Rs. (15000 + 13200 + 12000 + 9000 + 6000) = Rs. 55200.

Assuming that sales outside the house India will be 10% of these within India, the royalty coming from exterior India can be estimated at Rs. (1500 + 1320 + twelve hundred + 900 + 600) = Rs. 5520.

Hence, net revenue earned by IMC = Rs

= Rs. 60720

In such a case however , the revenue trickles in slowly

Tags:

Rainbows: Homosexuality and Butterflies Steve Conveniente Essay

Hemp to save lots of Our Forest Essay